ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

ALIMENT PHARM THER

ISSN / eISSN

0269-2813 / 1365-2036

Aims and Scope

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.

The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy.

AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.

Subject Area

PHARMACOLOGY & PHARMACY

GASTROENTEROLOGY & HEPATOLOGY

CiteScore

14.80

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Pharmacology (medical)	Q1	#7/260
Medicine - Gastroenterology	Q1	#6/149
Medicine - Hepatology	Q1	#8/70

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
GASTROENTEROLOGY & HEPATOLOGY - SCIE	Q1
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

159

Country/Area of Publication

ENGLAND

Publisher

Wiley-Blackwell Publishing Ltd

Publication Frequency

Semimonthly

Year Publication Started

1987

Annual Article Volume

236

Open Access

Contact

WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Popular journals in the same field
Recent articles

Clinical trial: predictive factors for response to gut‐directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis: (2023) Jade Devenney, Syed S. Hasan, Julie Morris, Peter J. Whorwell, Dipesh H. Vasant

Letter: Comparing first‐line infliximab and vedolizumab for ulcerative colitis—It depends on how you use the drug. Authors' reply: (2023) Bernd Bokemeyer, Sandra Plachta‐Danielzik

Letter: ‘No first among equals’: (2023) Umang Arora, Saurabh Kedia, Simon Travis, Vineet Ahuja

Systematic review and meta‐analysis: Foods, drinks and diets and their effect on chronic constipation in adults: (2023) Alice Van Der Schoot, Zoi Katsirma, Kevin Whelan, Eirini Dimidi

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks: (2023) Scott K. Fung, Calvin Q. Pan, Grace Lai‐Hung Wong, Wai‐Kay Seto, Sang Hoon Ahn, Chi‐Yi Chen, Hie‐Won L. Hann, Maciej S. Jablkowski, Yoon Jun Kim, Ciha...

Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis: (2023) Marlyn J. Mayo, John M. Vierling, Christopher L. Bowlus, Cynthia Levy, Gideon M. Hirschfield, Guy W. Neff, Michael R. Galambos, Stuart C. Gordon, Bria...

Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply: (2023) Selena Z. Kuo, Rohit Loomba

Editorial: PPIs and gastric cancer – Are we dealing with a carcinogen? Authors' reply: (2023) Eun Jeong Gong, Hye‐Kyung Jung

Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end: (2023) Lung‐Yi Mak

Letter: A step forward towards a standard FMT protocol for IBS: (2023) Magdy El‐Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation